Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
Journal of Medicinal Chemistry
|
September 29, 1995
Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor
D W McPherson, C R Lambert, K Jahn, et al.
Brain Research
|
July 31, 1995
Characterization of in vivo brain muscarinic acetylcholine receptor subtype selectivity by competition studies against (R,S)-[125I]IQNB
M S Gitler, S F Boulay, V K Sood, et al.
International Journal of Nuclear Medicine and Biology
|
January 1, 1984
Comparison of myocardial uptake and distribution of thallium-201 and two prototype receptor-binding radiopharmaceuticals in the normal and ischemic canine heart
W C Eckelman, W A Alter, M P Grissom, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|
July 1, 1992
Radiolabeled products in rat liver and serum after administration of antibody-amide-DTPA-indium-111
C H Paik, V K Sood, N Le, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1984
[I-125] 17 alpha-Iodovinyl 11 beta-methoxyestradiol: in vivo and in vitro properties of a high-affinity estrogen-receptor radiopharmaceutical
E M Jagoda, R E Gibson, H Goodgold, et al.
Journal of Medicinal Chemistry
|
October 1, 1984
Synthesis and evaluation of (17 alpha,20E)-21-[125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17 -diol and (17 alpha,20E)-21-[125I]iodo-11 beta-methoxy-19-norpregna-1,3,5(10),20-tetraene-3,17-diol (17 alpha-(iodovinyl)estradiol derivatives) as high specific activity potential radiopharmaceuticals
I Nakatsuka, N L Ferreira, W C Eckelman, et al.
International Journal of Nuclear Medicine and Biology
|
January 1, 1985
The labeling of high affinity sites of antibodies with 99mTc
C H Paik, L N Phan, J J Hong, et al.
Brain Research
|
April 13, 2000
In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones
V I Cohen, B Jin, R C McRee, et al.
Neuroimage
|
September 1, 1995
Autoradiographic evidence that quinuclidinyl 4-(bromophenyl)-2-thienylglycolate (QBPTG) displays in vivo selectivity for the muscarinic m2 subtype
S F Boulay, V K Sood, M R Rayeq, et al.
Nuclear Medicine and Biology
|
January 1, 1993
An improved synthesis of [125I]N-(diethylaminoethyl)-4-iodobenzamide: a potential ligand for imaging malignant melanoma
C S John, T Saga, S Kinuya, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
Journal of Medicinal Chemistry
|
September 29, 1995
Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor
D W McPherson, C R Lambert, K Jahn, et al.
Brain Research
|
July 31, 1995
Characterization of in vivo brain muscarinic acetylcholine receptor subtype selectivity by competition studies against (R,S)-[125I]IQNB
M S Gitler, S F Boulay, V K Sood, et al.
International Journal of Nuclear Medicine and Biology
|
January 1, 1984
Comparison of myocardial uptake and distribution of thallium-201 and two prototype receptor-binding radiopharmaceuticals in the normal and ischemic canine heart
W C Eckelman, W A Alter, M P Grissom, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|
July 1, 1992
Radiolabeled products in rat liver and serum after administration of antibody-amide-DTPA-indium-111
C H Paik, V K Sood, N Le, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1984
[I-125] 17 alpha-Iodovinyl 11 beta-methoxyestradiol: in vivo and in vitro properties of a high-affinity estrogen-receptor radiopharmaceutical
E M Jagoda, R E Gibson, H Goodgold, et al.
Journal of Medicinal Chemistry
|
October 1, 1984
Synthesis and evaluation of (17 alpha,20E)-21-[125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17 -diol and (17 alpha,20E)-21-[125I]iodo-11 beta-methoxy-19-norpregna-1,3,5(10),20-tetraene-3,17-diol (17 alpha-(iodovinyl)estradiol derivatives) as high specific activity potential radiopharmaceuticals
I Nakatsuka, N L Ferreira, W C Eckelman, et al.
International Journal of Nuclear Medicine and Biology
|
January 1, 1985
The labeling of high affinity sites of antibodies with 99mTc
C H Paik, L N Phan, J J Hong, et al.
Brain Research
|
April 13, 2000
In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones
V I Cohen, B Jin, R C McRee, et al.
Neuroimage
|
September 1, 1995
Autoradiographic evidence that quinuclidinyl 4-(bromophenyl)-2-thienylglycolate (QBPTG) displays in vivo selectivity for the muscarinic m2 subtype
S F Boulay, V K Sood, M R Rayeq, et al.
Nuclear Medicine and Biology
|
January 1, 1993
An improved synthesis of [125I]N-(diethylaminoethyl)-4-iodobenzamide: a potential ligand for imaging malignant melanoma
C S John, T Saga, S Kinuya, et al.
Page
of 17